View Older Stories View More Recent Stories

Nov 19, 2015 06:54AM Celladon (CLDN), Eiger BioPharma Enter Merger Agreement
Nov 18, 2015 10:36PM Eiger BioPharmaceuticals and Celladon Corporation Sign Merger Agreement
Nov 18, 2015 10:36PM Eiger BioPharmaceuticals and Celladon Corporation Sign Merger Agreement
Nov 18, 2015 05:30PM Form 4 Wave Life Sciences Ltd. For: Aug 14 Filed by: RA CAPITAL MANAGEMENT, LLC
Nov 18, 2015 04:47PM Form SC 13G/A ALCOBRA LTD. Filed by: RA CAPITAL MANAGEMENT, LLC
Nov 18, 2015 04:05PM Aclaris Therapeutics Reports Third Quarter 2015 Financial Results
Nov 18, 2015 04:05PM Aclaris Therapeutics Reports Third Quarter 2015 Financial Results
Nov 13, 2015 04:12PM Form 13F-HR RA CAPITAL MANAGEMENT, For: Sep 30
Oct 29, 2015 07:00AM Qvella Raises US$20M in Series A Financing From Leading US and Canadian Venture Funds
Oct 26, 2015 04:16PM Form SC 13G Strongbridge Biopharma Filed by: RA CAPITAL MANAGEMENT, LLC
Oct 21, 2015 04:35PM Form 4 Aclaris Therapeutics, For: Oct 19 Filed by: RA CAPITAL MANAGEMENT, LLC
Oct 21, 2015 08:00AM Arvinas Secures $41.6M Series B Financing - Appoints New Board Members
Oct 16, 2015 04:18PM Form 4 Aclaris Therapeutics, For: Oct 14 Filed by: RA CAPITAL MANAGEMENT, LLC
Oct 14, 2015 04:17PM Form SC 13G Zynerba Pharmaceuticals, Filed by: RA CAPITAL MANAGEMENT, LLC
Oct 13, 2015 09:34AM Form 4 Aclaris Therapeutics, For: Oct 07 Filed by: RA CAPITAL MANAGEMENT, LLC
Oct 13, 2015 09:28AM Form SC 13G Aclaris Therapeutics, Filed by: RA CAPITAL MANAGEMENT, LLC
Oct 13, 2015 08:00AM Audentes Therapeutics Raises $65 Million in Series C Financing
Oct 8, 2015 04:15PM Form SC 13G ZOGENIX, INC. Filed by: RA CAPITAL MANAGEMENT, LLC
Sep 29, 2015 05:10PM Form SC 13G/A SANGAMO BIOSCIENCES INC Filed by: RA CAPITAL MANAGEMENT, LLC
Sep 28, 2015 07:00AM Zafgen Announces Transition of Board of Directors
Sep 21, 2015 07:15AM Akari Therapeutics Closes $75 Million Private Placement
Sep 18, 2015 07:32AM Celsus Therapeutics (CLTX) Closes Acquisition of Volution Immuno Pharma
Sep 18, 2015 07:32AM Celsus Therapeutics and Volution Immuno Pharmaceuticals Announce Completion of Acquisition and Formation of Complement C5 Inhibitor Company Akari Therapeutics Plc
Aug 24, 2015 04:26PM RA Capital Shows New 9.6% Stake in Aquinox Pharmaceuticals (AQXP)
Aug 24, 2015 04:09PM Form SC 13G AQUINOX PHARMACEUTICALS, Filed by: RA CAPITAL MANAGEMENT, LLC
Aug 19, 2015 12:56PM Unusual 11 Mid-Day Movers 8/19: (CLTX) (HILL) (ACI) Higher; (RYAM) (TEDU) (FLXS) Lower
Aug 18, 2015 08:00AM WAVE Life Sciences Raises $66 Million in Series B Financing
Aug 18, 2015 07:18AM Celsus Therapeutics (CLTX), Volution Immuno Announce $75M Private Placement
Aug 18, 2015 07:16AM Celsus Therapeutics and Volution Immuno Pharmaceuticals Announce $75 Million Private Placement
Aug 13, 2015 04:25PM Form 13F-HR RA CAPITAL MANAGEMENT, For: Jun 30
Jul 23, 2015 09:00AM Ra Pharmaceuticals Announces $58.5M Series B Financing
Jul 22, 2015 04:00AM KalVista Pharmaceuticals Raises $33 Million to Advance Development of Novel Plasma Kallikrein Inhibitors in Diabetic Macular Edema and Hereditary Angioedema
Jul 8, 2015 10:20AM PlacementTracker Publishes First Half 2015 PIPE Market League Tables
Jul 7, 2015 06:03AM Form SC 13G ALCOBRA LTD. Filed by: RA CAPITAL MANAGEMENT, LLC
Jul 2, 2015 02:32AM Cortendo AB: Cortendo Provides 2015 Half-Year Update on Corporate Progress
Jun 25, 2015 04:42PM Form SC 13G ARCA biopharma, Inc. Filed by: RA CAPITAL MANAGEMENT, LLC
Jun 23, 2015 09:32AM Clementia Pharmaceuticals Raises U.S. $60 Million in Mezzanine Financing to Support Development of Palovarotene for Fibrodysplasia Ossificans Progressiva
Jun 17, 2015 09:00AM ARCA biopharma Announces Closing of $37 Million Private Placement
Jun 11, 2015 08:50AM ARCA biopharma Announces $37 Million Private Placement
Jun 5, 2015 05:14PM Form SC 13G ARDELYX, INC. Filed by: RA CAPITAL MANAGEMENT, LLC
Jun 4, 2015 07:30AM Calhoun Vision Raises $69 Million in Financing
Jun 3, 2015 06:20AM Ardelyx (ARDX) Announces $77.8M Common Stock, Warrants Offering
Jun 3, 2015 06:19AM Ardelyx to Raise $77.8 Million in a Private Placement and Announces New Product Candidate for the Treatment of Hyperkalemia to Begin Clinical Development in Mid-2015
May 15, 2015 04:16PM Form 13F-HR RA CAPITAL MANAGEMENT, For: Mar 31
May 15, 2015 04:06PM Form SC 13G COLLEGIUM PHARMACEUTICAL Filed by: RA CAPITAL MANAGEMENT, LLC
May 14, 2015 05:29PM Form SC 13G Xencor Inc Filed by: RA CAPITAL MANAGEMENT, LLC
May 8, 2015 04:14PM Form SC 13G Blueprint Medicines Corp Filed by: RA CAPITAL MANAGEMENT, LLC
May 8, 2015 04:12PM Form SC 13G Ascendis Pharma A/S Filed by: RA CAPITAL MANAGEMENT, LLC
Apr 21, 2015 04:50PM Form SC 13G Cidara Therapeutics, Filed by: RA CAPITAL MANAGEMENT, LLC
Apr 21, 2015 08:00AM Dimension Therapeutics Secures $65 Million in Oversubscribed Series B Financing
View More Recent Stories View Older Stories